RadioNano Therapeutics Inc. (Headquarters: Kyoto City, Kyoto Prefecture; Representative Director: Masatoshi Chiba; hereinafter referred to as "the Company") has received the "O-Nexus Award" at the open pitch of "U-START UP KANSAI 2026," a program supporting the business development of university-based startups. This program is organized by the Osaka Chamber of Commerce and Industry and the Kansai Innovation Initiative (KSII). Furthermore, we are pleased to announce that our P

RadioNano Therapeutics Inc. (Head Office: Kyoto, Japan; President & CEO: Dr.Masatoshi Chiba; hereinafter, the “Company”), a biotechnology company engaged in the research and development of inorganic nanoparticle formulations for Boron Neutron Capture Therapy (BNCT), today announced the successful completion of the first close of its Series B financing round through a third-party allotment of new shares to Mitsui Kinzoku Co., Ltd. and Kyoto University Innovation Capital Co., L

RadioNano Therapeutics Co., Ltd. (President and CEO: Masatoshi Chiba; hereinafter "the Company") is pleased to announce that its research theme, conducted in collaboration with Kyoto University and the Institute for Integrated Radiation and Nuclear Science, Kyoto University, has been selected for the "Ⅲ Full-Scale Business Development Course" under the Fiscal Year 2026 "Sangaku-ko no Mori" (Industry-Academia-Government Forest) Promotion Program, implemented by the Kyoto Small

We are pleased to announce that we have received the Grand Prize in an award program hosted by Ikeda Senshu Bank. As a supplementary prize, our Representative Director, Mr. Chiba, participated in a recording of the MBS Radio program “Nippon Ichi Akarui Keizai Denpa Shimbun” (Editor-in-Chief: Nobuo Takehara; Announcer: Hiroko Matsukawa). During the recording, we had the opportunity to discuss the initiatives that led to the award, our commitment to our business, and our future

The award ceremony for the 22nd Innovation Research & Development Grant , organized by The Ikeda Senshu Bank, Ltd. , was held, and our President and Chief Executive Officer, Mr. Chiba , attended the ceremony. This grant program aims to revitalize local communities by fostering the creation of new businesses through support for innovative and highly original business plans, as well as advanced research and development initiatives that contribute to solving social and regional

A conversation between our Representative Director and President, Masatoshi Chiba, and Professor Naoki Komatsu of the Graduate School of Human and Environmental Studies at Kyoto University — who is the inventor of the technology and serves as our Outside Director and Scientific Advisory Board Member — has been published on the official website of Kyoto University Innovation Capital Co., Ltd. The discussion covers the background of the development and its current progress. Kyo

The Kyoto City Venture Enterprise Screening Committee is a program established by the City of Kyoto to discover and nurture venture companies that will drive the industries of the next generation, comprehensively evaluating new business plans based on criteria such as novelty, business viability, market potential, and management philosophy. In this screening, we received high recognition for the novelty and innovation of our proprietary RN-501 technology, as well as the uniqu

RadioNano Therapeutics Inc. has been selected for the Grand Prize in the “22nd Innovation Research and Development Grant Program,” hosted by Ikeda Senshu Bank, Ltd. This grant program aims to revitalize local communities by supporting advanced research and development plans that contribute to solving social and regional issues, thereby fostering the creation of new businesses. Our company will continue to strive toward the social implementation of our novel boron‑containing n